Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
By targeting these pathways, tirzepatide can help reduce hunger, improve portion control, and support steady, sustainable weight loss over time
It is available to certain people ages 18 and older who are enrolled in Medicare Part D or a Medicare Advantage plan with prescription drug coverage, meet specific BMI or clinical criteria and are prescribed the medication along with structured nutrition and lifestyle changes
In addition, Semaglutide, another long-acting GLP-1 RA, has demonstrated superior efficacy in lowering blood glucose levels and reducing body weight compared to placebo or Liraglutide
Apr 28th, 2026 How Retatrutide Impacts Weight Loss and Metabolism Retatrutide is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors that has shown significant weight loss and metabolic benefits in trials, but it is not yet FDA-approved and remains available only in clinical studies
